Literature DB >> 30540661

Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic Patients.

Philip H Sossenheimer1, Laura R Glick1, Abraham H Dachman2,3, Kinga B Skowron2,4, Michele A Rubin2,4, Konstantin Umanskiy2,4, Radhika Smith2,4, Lisa M Cannon2,4, Roger D Hurst2,4, Russell D Cohen2,5, Neil H Hyman2,4, David T Rubin2,5.   

Abstract

BACKGROUND: Anastomotic complications after restorative total proctocolectomy with IPAA for ulcerative colitis alter functional outcomes and quality of life and may lead to pouch failure. Routine contrast enema of the pouch assesses anastomotic integrity before ileostomy reversal, but its clinical use is challenged.
OBJECTIVE: The purpose of this research was to assess the relationship among preoperative clinical characteristics, abnormal pouchography, and long-term pouch complications.
DESIGN: This was a retrospective chart review. SETTINGS: The study was conducted at a tertiary care center between 2000 and 2010. PATIENTS: Ulcerative colitis patients with IPAA undergoing pouchography before ileostomy closure were included. MAIN OUTCOME MEASURES: Patient demographics, incidence of pouch-related complications, and findings on pouchogram were recorded. Primary outcome was pouch failure, defined as excision or permanent diversion of the ileoanal pouch. Independent predictors of pouch failure were determined by multivariate regression.
RESULTS: A total of 262 patients with ulcerative colitis were included. Contrast extravasation was seen in 27 patients (10.3%): 14 (51.9%) were clinically asymptomatic at the time of pouchogram. Six (22.2%) of 27 patients with extravasation developed pouch failure despite normalization of the pouchogram before ileostomy closure. Forty patients (15.3%) were found to have pouch-anal anastomotic stenosis; only 1 developed pouch failure. Pre-IPAA serum albumin and hemoglobin levels were inversely associated with contrast extravasation (serum albumin: OR = 0.42; hemoglobin: OR = 0.77; p < 0.05). Contrast extravasation was associated with delayed takedown operation (average = 67 d), increased risk (OR = 5.25; p < 0.01), and shorter time (median = 32.0 vs 72.5 mo; HR = 5.88; p < 0.05) to pouch failure, as well as increased risk of pouch-related complications (p < 0.05). LIMITATIONS: The study was limited by its retrospective nature and small number of patients who developed pouch failure.
CONCLUSIONS: Pouchography before ileostomy takedown is useful in identifying patients with ulcerative colitis at risk for postoperative complications. Radiologic resolution of IPAA-related leak does not reliably predict healing; caution is warranted in this subgroup. See Video Abstract at http://links.lww.com/DCR/A818.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30540661     DOI: 10.1097/DCR.0000000000001285

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

Review 1.  Disease Monitoring of the Ileoanal Pouch: How to Utilize Biomarkers, Imaging, and Pouchoscopy.

Authors:  Edward L Barnes; Kimberly Darlington; Hans H Herfarth
Journal:  Curr Gastroenterol Rep       Date:  2022-10-18

2.  Perfusion Visualization during Ileal J-Pouch Formation-A Proposal for the Standardization of Intraoperative Imaging with Indocyanine Green Near-Infrared Fluorescence and a Postoperative Follow-Up in IBD Surgery.

Authors:  Leonard A Lobbes; Susanne Berns; René Warschkow; Leonard R Schmidt; Christian Schineis; Rahel M Strobel; Johannes C Lauscher; Katharina Beyer; Benjamin Weixler
Journal:  Life (Basel)       Date:  2022-04-30

Review 3.  Staging Pouch Surgery in Ulcerative Colitis in the Biological Era.

Authors:  Anton Risto; Maie Abdalla; Pär Myrelid
Journal:  Clin Colon Rectal Surg       Date:  2022-01-17

4.  Endo-sponge Assisted Early Surgical Closure of Ileal Pouch-anal Anastomotic Leakage Preserves Long-term Function: A Cohort Study.

Authors:  Karin A Wasmann; Maud A Reijntjes; Merel E Stellingwerf; Cyriel Y Ponsioen; Christianne J Buskens; Roel Hompes; Pieter J Tanis; Willem A Bemelman
Journal:  J Crohns Colitis       Date:  2019-12-10       Impact factor: 9.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.